Total Payments
$87,524
2024 Payments
$108.57
Companies
23
Transactions
154
Medicare Patients
414
Medicare Billing
$49,305
Payment Breakdown by Category
Other$43,306 (49.5%)
Travel$21,246 (24.3%)
Research$13,080 (14.9%)
Consulting$5,100 (5.8%)
Food & Beverage$4,776 (5.5%)
Education$16.11 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $37,556 | 13 | 42.9% |
| Travel and Lodging | $21,246 | 30 | 24.3% |
| Unspecified | $13,080 | 1 | 14.9% |
| Honoraria | $5,750 | 3 | 6.6% |
| Consulting Fee | $5,100 | 3 | 5.8% |
| Food and Beverage | $4,776 | 103 | 5.5% |
| Education | $16.11 | 1 | 0.0% |
Payments by Type
General
$74,444
153 transactions
Research
$13,080
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $27,865 | 4 | $0 (2017) |
| Mylan Specialty L.P. | $15,262 | 29 | $0 (2017) |
| Greer Laboratories, Inc. | $14,039 | 27 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $13,350 | 14 | $0 (2021) |
| ALK-Abello, Inc | $6,351 | 13 | $0 (2022) |
| BOSTON SCIENTIFIC CORPORATION | $3,738 | 3 | $0 (2017) |
| F. Hoffmann-La Roche AG | $2,421 | 3 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $1,040 | 5 | $0 (2018) |
| Mylan Pharmaceuticals Inc. | $1,000 | 1 | $0 (2018) |
| Optinose US, Inc. | $750.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $108.57 | 4 | Genentech USA, Inc. ($55.87) |
| 2023 | $121.18 | 5 | Genentech USA, Inc. ($52.29) |
| 2022 | $197.55 | 10 | Regeneron Healthcare Solutions, Inc. ($67.01) |
| 2021 | $75.62 | 4 | Takeda Pharmaceuticals U.S.A., Inc. ($40.35) |
| 2020 | $13,216 | 8 | Novartis Pharmaceuticals Corporation ($13,136) |
| 2019 | $320.72 | 14 | Novartis Pharmaceuticals Corporation ($146.35) |
| 2018 | $5,808 | 27 | F. Hoffmann-La Roche AG ($2,421) |
| 2017 | $67,676 | 82 | Merck Sharp & Dohme Corporation ($27,865) |
All Payment Transactions
154 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $32.14 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $36.08 | General |
| Category: Immunology | ||||||
| 03/22/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Immunology | ||||||
| 08/22/2023 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: Immunology | ||||||
| 08/03/2023 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: IMMUNOLOGY | ||||||
| 06/29/2023 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $27.19 | General |
| Category: Immunology | ||||||
| 03/02/2023 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $37.41 | General |
| Category: Allergy | ||||||
| 02/02/2023 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: IMMUNOLOGY | ||||||
| 10/27/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/06/2022 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Allergy | ||||||
| 08/18/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/05/2022 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Immunology | ||||||
| 06/09/2022 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Immunology | ||||||
| 05/05/2022 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: IMMUNOLOGY | ||||||
| 04/08/2022 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Immunology | ||||||
| 03/17/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/04/2022 | ALK-Abello, Inc | Odactra (Drug), Grastek, Ragwitek | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Allergy and Immunology | ||||||
| 01/21/2022 | Bio Products Laboratory USA, Inc. | Gammaplex (Drug) | Food and Beverage | Cash or cash equivalent | $14.13 | General |
| Category: IVIG | ||||||
| 09/16/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: GENETIC DISEASE | ||||||
| 08/12/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: IMMUNOLOGY | ||||||
| 06/24/2021 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: IMMUNOLOGY | ||||||
| 05/06/2021 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $16.68 | General |
| 12/03/2020 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: IMMUNOLOGY | ||||||
| 10/06/2020 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | — | Cash or cash equivalent | $13,080.00 | Research |
| Study: OUTCOMES RESEARCH • Category: RESPIRATORY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| OUTCOMES RESEARCH | Novartis Pharmaceuticals Corporation | $13,080 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 109 | 181 | $42,647 | $13,134 |
| 2022 | 3 | 111 | 619 | $44,525 | $13,388 |
| 2021 | 2 | 121 | 176 | $42,432 | $14,565 |
| 2020 | 2 | 73 | 126 | $25,533 | $8,217 |
Total Patients
414
Total Services
1,102
Medicare Billing
$49,305
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 144 | $31,806 | $9,794 | 30.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $10,841 | $3,340 | 30.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 125 | $26,829 | $8,348 | 31.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $10,841 | $3,675 | 33.9% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 12 | 457 | $6,855 | $1,365 | 19.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 112 | $23,680 | $8,253 | 34.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 64 | 64 | $18,752 | $6,312 | 33.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 46 | 99 | $17,622 | $5,710 | 32.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 27 | 27 | $7,911 | $2,507 | 31.7% |
About Dr. David Skoner, MD
Dr. David Skoner, MD is a Pediatric Allergy/Immunology healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1972504165.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Skoner, MD has received a total of $87,524 in payments from pharmaceutical and medical device companies, with $108.57 received in 2024. These payments were reported across 154 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($37,556).
As a Medicare-enrolled provider, Skoner has provided services to 414 Medicare beneficiaries, totaling 1,102 services with total Medicare billing of $49,305. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Pediatric Allergy/Immunology
- Location Pittsburgh, PA
- Active Since 08/10/2005
- Last Updated 04/15/2022
- Taxonomy Code 2080P0201X
- Entity Type Individual
- NPI Number 1972504165
Products in Payments
- Dymista (Drug) $14,762
- Oralair (Drug) $14,039
- XOLAIR (Biological) $13,312
- Grastek (Biological) $4,045
- GENERAL - BRONCHIAL THERMOPLASTY (Device) $3,600
- Xolair (Biological) $2,708
- Odactra (Biological) $1,750
- EpiPen (Drug) $1,500
- PROAIR RESPICLICK (Drug) $850.71
- Xhance (Drug) $750.00
- Auvi-Q (Drug) $378.66
- Odactra (Drug) $223.66
- ALAIR (Device) $138.20
- FASENRA (Drug) $124.07
- EUCRISA (Drug) $112.40
- QVAR (Drug) $112.24
- DUPIXENT (Biological) $110.54
- DUPIXENT (Drug) $89.00
- HYQVIA (Biological) $79.92
- CINQAIR (Drug) $77.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.